2 February 2020
This report describes a stage I uveal melanoma patient treated with oncolytic virus Rigvir as an adjuvant therapy.
Read more: https://www.sciencedirect.com/science/article/pii/S245199362030013X
Rigvir Group
Address: Atlasa street 7C, Riga, Latvia, LV-1026
E-mail: pr@rigvir.com